Epilepsy Research
Volume 30, Issue 1 , Pages 63-68 , March 1998

Inhibition of pentylenetetrazol-induced seizures in rats by prostaglandin D2

Received 13 August 1997 ,Revised 27 October 1997 ,Accepted 28 October 1997.

References 

  1. Abdel-Halim MS, Hamberg M, Sjoquist B, Anggard E. Identification of prostaglandin D2 as a major prostaglandin in homogenates of rat brain. Prostaglandins. 1977;14:633–643
  2. Akarsu ES, Ayhan IH. Iloprost, a stable analogue of PGI2, potentiates the hyperthermic effect of PGE2 in rats. Pharmacol. Biochem. Behav. 1993;46:383–389
  3. Bazan NG, Birkle DL, Tang W, Redoly TS. The accumulation of free arachidonic acid, diacylglycerols, prostaglandins and lipoxygenase reaction products in the brain during experimental epilepsy. In:  Delgado-Escueta AV,  Ward AA,  Woodbury DM,  Porter RJ editor. Advanced Neurology. New York: Raven Press; 1986;p. 879–902
  4. Berchtold-Kanz E, Anhut H, Heldt R, Neufang B, Hertting G. Regional distribution of arachidonic acid metabotites in rat brain following convulsive stimuli. Prostaglandins. 1981;22:65–79
  5. Coleman RA, Kennedy I, Sheldrick RLG. AH 6809, a prostanoid EP1, receptor blocking drug. Br. J. Pharmacol. 1985;85:273P
  6. Darius H, Michael-Hepp J, Thierauch K-H, Fisch A. Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182. Eur. J. Pharmacol. 1994;258:207–213
  7. Eglen RM, Whiting RL. The actions of prostanoid receptor agonist and antagonist on smooth muscle and platelets. Br. J. Pharmacol. 1988;94:591–601
  8. Forstermann U, Heldt R, Knappen F, Hertting G. Potential anticonvulsive properties of endogenous prostaglandins formed in mouse brain. Brain Res. 1982;240:303–310
  9. Forstermann U, Heldt R, Hertting G. Increase in brain prostaglandins during convulsions is due to increased neuronal activity and not to hypoxia. Arc. Int. Pharmacodyn. 1983;263:180–188
  10. Forstermann U, Heldt R, Hertting G. Effects of intracerebroventricular administration of prostaglandin D2 on behavior, blood pressure and body temperature as compared to prostaglandins E2 and F2a. Psychopharmacology. 1983;80:365–370
  11. Forstermann U, Seregi A, Hertting G. Anticonvulsive effects of endogenous prostaglandins formed in brain of spontaneously convulsing gerbils. Prostaglandins. 1984;27:913–923
  12. Hayaishi O. Prostaglandin D2: a neuromodulator. In:  Samuelsson B,  Paoletti R,  Ramwell P editor. Advances in Prostaglandin, Thromboxane, and Leukotriene Research,. 12:NewYork: Raven Press; 1983;p. 333–337
  13. Hayaishi O. Molecular mechanisms of sleep–wake regulation: roles of prostaglandins D2 and E2. FASEB J. 1991;5:2575–2581
  14. Hertting G, Seregi A, Forstermann U. Formation and functions of prostaglandins in the central nervous system in rodents. In:  Hayaishi O,  Yamamoto S editor. Advances in Prostaglandins, Thromboxane, and Leukotriene Research. 15:New York: Raven Press; 1985;p. 573–576
  15. Islam F, Watanabe Y, Morii H, Hayaishi O. Inhibition of rat brain prostaglandin D syntase by inorganic selenocompounds. Arc. Biochem. Biophys. 1991;289:161–166
  16. Keery RJ, Lumley P. AH 6809, a selective antagonist at the human platelet DP-receptors?. Br. J. Pharmacol. 1985;85:286P
  17. Kimura H, Okamoto K, Sakai Y. Modulatory effects of prostaglandins D2, E2 and F2α on the postsynaptic actions of inhibitory and excitatory aminoacids in cerebellar purkinje cell dendrites in vitro. Brain Res. 1985;330:235–244
  18. Matsumura H, Takahata R, Hayaishi O. Inhibition of sleep in rats by inorganic selenium compounds, inhibitors of prostaglandin D synthase. Proc. Natl. Acad. Sci. USA. 1991;88:9046–9050
  19. Naffah-Mazzacorati MG, Bellissimo MI, Cavalheiro EA. Profile of prostaglandin levels in the rat hippocampus in pilocarpine model of epilepsy. Neurochem. Int. 1995;27:461–466
  20. Narumiya S, Ogorochi T, Nakao K, Hayaishi O. Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sci. 1982;31:2093–2103
  21. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Sydney: Academic Press; 1982;
  22. Schulz BG, Beckmann R, Muller B, Schroder G, Maass B, Thierauch K-H, et al. Cardio- and hemodynamic profile of selective PGD2 analogues. In:  Samuelsonn B editors. Advances in Prostaglandins, Thromboxane and Leukotriene Research. 21:New York: Raven Press; 1990;p. 591–594
  23. Seregi A, Forstermann U, Hertting G. Decreased levels of brain cyclo-oxygenase products as a possible cause of increased seizure susceptibility in convulsion-prone gerbils. Brain Res. 1984;305:393–395
  24. Seregi A, Folly G, Heldt R, Vizi ES, Hertting G. Differential prostaglandin formation induced by convulsions in the brain of mice susceptible (DBA/2J) and resistant (CFLP) to acoustic stimulation. Epilepsy Res. 1990;5:131–136
  25. Steinhauer HB, Hertting G. Lowering of the convulsive threshold by nonsteroidal antiinflamatory drugs. Eur. J. Pharmacol. 1981;69:199–203
  26. Wheeldon A, Vardey CJ. Characterization of the inhibitory prostanoid receptors on human neutrophils. Br. J. Pharmacol. 1993;108:1051–1054
  27. Wolfe LS. Eicosanoids: prostaglandins, thromboxanes, leukotrienes and other derivatives of carbon-20 unsaturated fatty acids. J. Neurochem. 1982;38:1–16

PII: S0920-1211(97)00092-2

Epilepsy Research
Volume 30, Issue 1 , Pages 63-68 , March 1998

Article Tools